Document is current
Any future updates will be listed below
-
Authors
Milligan, Carol J. http://orcid.org/0000-0003-0353-7228
Anderson, Lyndsey L.
Bowen, Michael T.
Banister, Samuel D.
McGregor, Iain S.
Arnold, Jonathon C.
Petrou, Steven
-
Funding
Funding for this research was provided by:
lambert initiative for cannabinoid therapeutics
- License Information
-
More Information
Article History
Received: 16 July 2021
Accepted: 8 May 2022
First Online: 10 June 2022
Declarations
:
: Not applicable
: Not applicable
: Associate Professor Jonathon Arnold is Deputy Academic Director of the Lambert Initiative. He has served as an expert witness in various medicolegal cases involving cannabis and cannabinoids and served as a temporary advisor to the World Health Organization on their review of cannabis and cannabinoids. Associate Professor Arnold has received consulting fees from Creo Inc. and Medicinal Cannabis Industry Australia (MCIA). Professor Iain McGregor is Academic Director of the Lambert Initiative for Cannabinoid Therapeutics. He has served as an expert witness in various medicolegal cases involving cannabis, has received honoraria from Janssen, is currently a consultant to Kinoxis Therapeutics and has received research funding and fellowship support from the Lambert Initiative, NHMRC and Australian Research Council. He currently sits on medical advisory board of BOD Australia and holds a variety of patents for non-cannabinoid therapeutics. Associate Professor Arnold and Professor McGregor hold patents on cannabinoid therapies (PCT/AU2018/05089 and PCT/AU2019/050554). The nutraceutical product tested in this study was provided by Ananda Professional Pty Ltd, a subsidiary of Ecofibre Limited. Ananda Professional Pty Ltd and Ecofibre Limited played no part in the design, conduct, analysis, writing or decision to publish this work.
